RVPH (STOCKS)
Reviva Pharmaceuticals Holdings, Inc. Common Stock
$0.860000
+0.089100 (+11.56%)
Prev close: $0.770900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Laxminarayan Bhat
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10.97M
- Employees
- 14
- P/E (TTM)
- -0.13
- P/B (TTM)
- 0.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.20 | $-1.98 | +0.7817 | +39.45% |
|
Jun 2025 (Q2)
|
$-2.40 | $-2.24 | -0.1560 | -6.95% |
|
Mar 2025 (Q1)
|
$-2.60 | $-3.72 | +1.1230 | +30.16% |
|
Dec 2024 (Q4)
|
$-3.00 | $-4.39 | +1.3860 | +31.60% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $354.02K |
| Operating Expenses | $20.20M |
| Research and Development | $11.71M |
| Other Operating Expenses | $8.49M |
| Operating Income/Loss | -$20.20M |
| Income/Loss From Continuing Operations After Tax | -$19.86M |
| Income/Loss From Continuing Operations Before Tax | -$19.85M |
| Income Tax Expense/Benefit | $18.89K |
| Income Tax Expense/Benefit, Current | $18.89K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$19.86M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.86M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.86M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.48 |
| Basic Average Shares | 3,627,890 |
| Assets | $15.92M |
| Current Assets | $15.10M |
| Noncurrent Assets | $819.72K |
| Liabilities | $7.28M |
| Current Liabilities | $7.28M |
| Accounts Payable | $3.01M |
| Wages | $485.90K |
| Other Current Liabilities | $3.78M |
| Noncurrent Liabilities | $0.00 |
| Equity | $8.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $8.65M |
| Liabilities And Equity | $15.92M |
| Net Cash Flow From Operating Activities | -$24.59M |
| Net Cash Flow From Operating Activities, Continuing | -$24.59M |
| Net Cash Flow From Investing Activities | -$962.46K |
| Net Cash Flow From Investing Activities, Continuing | -$962.46K |
| Net Cash Flow From Financing Activities | $25.56M |
| Net Cash Flow From Financing Activities, Continuing | $25.56M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$19.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.86M |
| Other Comprehensive Income/Loss | $0.00 |